Histological assessment based on liver biopsy: the value and challenges in NASH drug development
Xiaofei Tong(Capital Medical University), Hong You(Harbin Institute of Technology), Xinyan Zhao(Capital Medical University), Liling Yang(Capital Medical University), Qianyi Wang(Capital Medical University), Xiaoning Wu(First Affiliated Hospital of Xi'an Jiaotong University), Zhengzhao Lu(Capital Medical University), Jidong Jia(National Clinical Research Center for Digestive Diseases), Xiaojuan Ou(Capital Medical University), Yameng Sun(Renji Hospital)
Cited by 42
Related Papers
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
|Journal of Hepatology|2020|346
Impact of Nonoptimal Intakes of Saturated, Polyunsaturated, and Trans Fat on Global Burdens of Coronary Heart Disease
|Journal of the American Heart Association|2016|164
New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment
|Hepatology|2016|156